OBJECTIVES: The aim of this study was to assess the influence of enrolling site location and enrollment performance on the generalizability of STICH (Surgical Treatment for Ischemic Heart Failure) trial results. BACKGROUND: The international STICH trial seeks to define the role of cardiac surgery for patients with ischemic cardiomyopathy. METHODS: Baseline characteristics of 2,136 randomized STICH patients were entered into a multivariate equation created using the Duke Databank for Cardiovascular Diseases to predict their 5-year risk for death without cardiac surgery. Patients ordered by increasing predicted risk were assigned to 1 of 32 risk at randomization (RAR) groups created to share one-thirty-second of total predicted deaths. Numbers of patients sharing the same RAR group were compared between higher and lower enrolling site groupings and for countries tending to enroll high- or low-risk patients. RESULTS: Country of enrollment was a stronger determinant of risk diversity than site enrollment performance among patients enrolled at 127 sites in 26 countries. Mean RAR differences among countries ranged from 9.4 (Singapore) to 18.6 (Germany). However, 1,614 of 2,136 patients (76%) from countries enrolling lower-risk patients shared the same RAR group with patients from countries enrolling higher-risk patients. Baseline characteristics responsible for risk differences of patients enrolled in the 2 country groupings were sufficiently similar to exert little influence on clinical decision making. CONCLUSIONS:STICH randomized patients are characterized by a continuous spectrum of risk, without discordant dominance from any site or country. Clinical site diversity promises to enhance the generalization of STICH trial results to a broad population of patients with ischemic cardiomyopathy. (Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease; NCT00023595). Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
RCT Entities:
OBJECTIVES: The aim of this study was to assess the influence of enrolling site location and enrollment performance on the generalizability of STICH (Surgical Treatment for Ischemic Heart Failure) trial results. BACKGROUND: The international STICH trial seeks to define the role of cardiac surgery for patients with ischemic cardiomyopathy. METHODS: Baseline characteristics of 2,136 randomized STICH patients were entered into a multivariate equation created using the Duke Databank for Cardiovascular Diseases to predict their 5-year risk for death without cardiac surgery. Patients ordered by increasing predicted risk were assigned to 1 of 32 risk at randomization (RAR) groups created to share one-thirty-second of total predicted deaths. Numbers of patients sharing the same RAR group were compared between higher and lower enrolling site groupings and for countries tending to enroll high- or low-risk patients. RESULTS: Country of enrollment was a stronger determinant of risk diversity than site enrollment performance among patients enrolled at 127 sites in 26 countries. Mean RAR differences among countries ranged from 9.4 (Singapore) to 18.6 (Germany). However, 1,614 of 2,136 patients (76%) from countries enrolling lower-risk patients shared the same RAR group with patients from countries enrolling higher-risk patients. Baseline characteristics responsible for risk differences of patients enrolled in the 2 country groupings were sufficiently similar to exert little influence on clinical decision making. CONCLUSIONS: STICH randomized patients are characterized by a continuous spectrum of risk, without discordant dominance from any site or country. Clinical site diversity promises to enhance the generalization of STICH trial results to a broad population of patients with ischemic cardiomyopathy. (Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease; NCT00023595). Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Authors: Seth W Glickman; John G McHutchison; Eric D Peterson; Charles B Cairns; Robert A Harrington; Robert M Califf; Kevin A Schulman Journal: N Engl J Med Date: 2009-02-19 Impact factor: 91.245
Authors: Gerald T O'Connor; Elaine M Olmstead; William C Nugent; Bruce J Leavitt; Robert A Clough; Paul W Weldner; David C Charlesworth; Kristine Chaisson; Donato Sisto; Edward R Nowicki; Richard P Cochran; David J Malenka Journal: J Am Coll Cardiol Date: 2008-06-17 Impact factor: 24.094
Authors: R M Califf; F E Harrell; K L Lee; J S Rankin; M A Hlatky; D B Mark; R H Jones; L H Muhlbaier; H N Oldham; D B Pryor Journal: JAMA Date: 1989-04-14 Impact factor: 56.272
Authors: R H Jones; K Kesler; H R Phillips; D B Mark; P K Smith; C L Nelson; M F Newman; J G Reves; R W Anderson; R M Califf Journal: J Thorac Cardiovasc Surg Date: 1996-05 Impact factor: 5.209
Authors: Peter K Smith; Robert M Califf; Robert H Tuttle; Linda K Shaw; Kerry L Lee; Elizabeth R Delong; R Eric Lilly; Michael H Sketch; Eric D Peterson; Robert H Jones Journal: Ann Thorac Surg Date: 2006-10 Impact factor: 4.330
Authors: John E A Blair; Faiez Zannad; Marvin A Konstam; Thomas Cook; Brian Traver; John C Burnett; Liliana Grinfeld; Holly Krasa; Aldo P Maggioni; Cesare Orlandi; Karl Swedberg; James E Udelson; Christopher Zimmer; Mihai Gheorghiade Journal: J Am Coll Cardiol Date: 2008-11-11 Impact factor: 24.094
Authors: Eric J Velazquez; Kerry L Lee; Christopher M O'Connor; Jae K Oh; Robert O Bonow; Gerald M Pohost; Arthur M Feldman; Daniel B Mark; Julio A Panza; George Sopko; Jean L Rouleau; Robert H Jones Journal: J Thorac Cardiovasc Surg Date: 2007-12 Impact factor: 5.209
Authors: Robert H Jones; Eric J Velazquez; Robert E Michler; George Sopko; Jae K Oh; Christopher M O'Connor; James A Hill; Lorenzo Menicanti; Zygmunt Sadowski; Patrice Desvigne-Nickens; Jean-Lucien Rouleau; Kerry L Lee Journal: N Engl J Med Date: 2009-03-29 Impact factor: 91.245
Authors: Thomas A Holly; Robert O Bonow; J Malcolm O Arnold; Jae K Oh; Padmini Varadarajan; Gerald M Pohost; Haissam Haddad; Robert H Jones; Eric J Velazquez; Bozena Birkenfeld; Federico M Asch; Marcin Malinowski; Rodrigo Barretto; Renato A K Kalil; Daniel S Berman; Jie-Lena Sun; Kerry L Lee; Julio A Panza Journal: J Thorac Cardiovasc Surg Date: 2014-07-30 Impact factor: 5.209
Authors: Nadia Bouabdallaoui; Susanna R Stevens; Torsten Doenst; Mark C Petrie; Nawwar Al-Attar; Imtiaz S Ali; Andrew P Ambrosy; Anna K Barton; Raymond Cartier; Alexander Cherniavsky; Pierre Demondion; Patrice Desvigne-Nickens; Robert R Favaloro; Sinisa Gradinac; Petra Heinisch; Anil Jain; Marek Jasinski; Jerome Jouan; Renato A K Kalil; Lorenzo Menicanti; Robert E Michler; Vivek Rao; Peter K Smith; Marian Zembala; Eric J Velazquez; Hussein R Al-Khalidi; Jean L Rouleau Journal: Circ Heart Fail Date: 2018-11 Impact factor: 8.790
Authors: Bert Andersson; Lilin She; Ru-San Tan; Panniyammakal Jeemon; Krzysztof Mokrzycki; Matthias Siepe; Alexander Romanov; Liliana E Favaloro; Ljubomir T Djokovic; P Krishnam Raju; Piotr Betlejewski; Normand Racine; Adam Ostrzycki; Weerachai Nawarawong; Siuli Das; Jean L Rouleau; George Sopko; Kerry L Lee; Eric J Velazquez; Julio A Panza Journal: Eur Heart J Date: 2018-10-01 Impact factor: 29.983
Authors: Marian Zembala; Robert E Michler; Andrzej Rynkiewicz; Thao Huynh; Lilin She; Barbara Lubiszewska; James A Hill; Ruzena Jandova; Francois Dagenais; Eric D Peterson; Robert H Jones Journal: J Am Coll Cardiol Date: 2010-08-03 Impact factor: 24.094
Authors: Marek A Deja; Paul A Grayburn; Benjamin Sun; Vivek Rao; Lilin She; Michal Krejca; Anil R Jain; Yeow Leng Chua; Richard Daly; Michele Senni; Krzysztof Mokrzycki; Lorenzo Menicanti; Jae K Oh; Robert Michler; Krzysztof Wróbel; Andre Lamy; Eric J Velazquez; Kerry L Lee; Robert H Jones Journal: Circulation Date: 2012-05-02 Impact factor: 29.690
Authors: Robert O Bonow; Serenella Castelvecchio; Julio A Panza; Daniel S Berman; Eric J Velazquez; Robert E Michler; Lilin She; Thomas A Holly; Patrice Desvigne-Nickens; Dragana Kosevic; Miroslaw Rajda; Lukasz Chrzanowski; Marek Deja; Kerry L Lee; Harvey White; Jae K Oh; Torsten Doenst; James A Hill; Jean L Rouleau; Lorenzo Menicanti Journal: JACC Cardiovasc Imaging Date: 2015-09-09
Authors: Krzysztof Wrobel; Susanna R Stevens; Robert H Jones; Craig H Selzman; Andre Lamy; Thomas M Beaver; Ljubomir T Djokovic; Nan Wang; Eric J Velazquez; George Sopko; Irving L Kron; J Michael DiMaio; Robert E Michler; Kerry L Lee; Michael Yii; Chua Yeow Leng; Marian Zembala; Jean L Rouleau; Richard C Daly; Hussein R Al-Khalidi Journal: Circulation Date: 2015-08-25 Impact factor: 29.690
Authors: Julio A Panza; Thomas A Holly; Federico M Asch; Lilin She; Patricia A Pellikka; Eric J Velazquez; Kerry L Lee; Salvador Borges-Neto; Pedro S Farsky; Robert H Jones; Daniel S Berman; Robert O Bonow Journal: J Am Coll Cardiol Date: 2013-03-07 Impact factor: 24.094